316-330 of 388
Stories of Psoriatic Arthritis: A Mother's Journey to Recovery
Beyond Skin Deep: Impacts of Psoriatic ArthritisStories of Psoriatic Arthritis: A Mother's Journey to Recovery
Matt Birnholz, MD
Robin K. Dore, MD
Stories of Psoriatic Arthritis: One Patient's Lifelong Affliction
Beyond Skin Deep: Impacts of Psoriatic ArthritisStories of Psoriatic Arthritis: One Patient's Lifelong Affliction
Matt Birnholz, MD
Robin Dore, MD
How PASI Scores Redefine Psoriatic Arthritis Patient Care
Beyond Skin Deep: Impacts of Psoriatic ArthritisHow PASI Scores Redefine Psoriatic Arthritis Patient Care
Robin K. Dore, MD
Understanding Treat-to-Target Strategy in the Management of PsA
Beyond Skin Deep: Impacts of Psoriatic ArthritisUnderstanding Treat-to-Target Strategy in the Management of PsA
Elizabeth Volkmann, MD, MS
Minimal Disease Activity as Alternate Target in PsA
Beyond Skin Deep: Impacts of Psoriatic ArthritisMinimal Disease Activity as Alternate Target in PsA
Elizabeth Volkmann, MD, MS
Why Clinical Skills are Crucial to Early Psoriatic Arthritis Diagnosis
Beyond Skin Deep: Impacts of Psoriatic ArthritisWhy Clinical Skills are Crucial to Early Psoriatic Arthritis Diagnosis
J. Eugene Huffstutter, MD
- advertisement
The Impact of Positive Communication with PsA Patients
Beyond Skin Deep: Impacts of Psoriatic ArthritisThe Impact of Positive Communication with PsA Patients
J. Eugene Huffstutter, MD
Could You Be Missing Symptoms in Your PsA Patients?
Beyond Skin Deep: Impacts of Psoriatic ArthritisCould You Be Missing Symptoms in Your PsA Patients?
J. Eugene Huffstutter, MD
How You Can Overcome the Biggest Challenge in PsA Care Coordination
Beyond Skin Deep: Impacts of Psoriatic ArthritisHow You Can Overcome the Biggest Challenge in PsA Care Coordination
J. Eugene Huffstutter, MD
Jennifer Caudle, DO, FACOFP
Jennifer Caudle, DO, FACOFP
Knowing your Patient's Melanoma Risk Factors
Everyday Family MedicineKnowing your Patient's Melanoma Risk Factors
Jennifer Caudle, DO, FACOFP
- advertisement
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
Project Oncology®FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
Michael S.Miller, DO, FACOS, FAPWCA, WCC
Identifying and Treating the Red Leg: Is It All in Vein?
The Word on Wound CareIdentifying and Treating the Red Leg: Is It All in Vein?
Michael S.Miller, DO, FACOS, FAPWCA, WCC
